Skip to content
healthcare.dev

Lansoprazole

NDC 0093-7350, Lansoprazole, capsule, delayed release, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-7350
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077255
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7350 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE15 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
0093-7350-560009373505630 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-7350-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/427cf924-be17-47dc-8f77-115fa2f3fe17
  • NADAC price for package 00093735056

    GET /v1/drugs/nadac/00093735056

Use it

Look up 0093-7350 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-7350 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-7350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.